ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	40/644	73/6049	8.4247302411613e-21	4.07756943672207e-18	3.3078151367928e-18	6356/6357/6361/6362/6347/6364/6370/10344/6348/6351/9560/1437/1440/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3586/3589/3605/29949/3552/3553/3557/51561/11009/3569/4312/4314/4318/5008/5196/6696/7124	40
WP5055	Burn wound healing	37/644	97/6049	6.57409731456198e-13	1.590931550124e-10	1.29059910438506e-10	8038/6347/57124/1277/1278/2919/3579/2162/2200/3082/3383/3552/3553/3569/3624/3853/23643/440823/4312/4322/4313/4314/4318/64332/64127/5159/6282/6280/6423/6678/7042/7043/7076/7097/51311/3371/7124	37
WP5115	Network map of SARS-CoV-2 signaling pathway	55/644	190/6049	1.05290315754923e-12	1.69868376084609e-10	1.37801009742408e-10	59272/183/335/341/8542/684/715/838/6356/6347/6364/10344/6348/6351/1234/1051/629/3426/5199/1294/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/3091/10964/8519/10410/3458/3586/3605/8807/3552/3553/3569/3699/3726/116844/64386/114548/4939/5196/5743/6288/6289/6403/5054/6772/7124	55
WP2806	Complement system	30/644	75/6049	2.56843242827315e-11	3.10780323821051e-09	2.52111919933127e-09	133/335/715/717/720/722/728/27202/958/1604/22918/629/3426/5199/2162/2214/2219/2357/2769/3383/3687/3689/5648/5329/6401/6402/6403/710/6696/7097	30
WP4891	COVID-19 adverse outcome pathway	11/644	13/6049	1.17556210810056e-09	1.13794412064134e-07	9.23125613308441e-08	59272/183/6347/6348/1440/3627/3586/3553/3559/3569/7124	11
WP3624	Lung fibrosis	22/644	52/6049	3.44356482575142e-09	2.77780895943948e-07	2.25342049123733e-07	6356/6347/6348/6351/1232/1051/1215/1437/1440/2920/57105/2252/26585/3082/3553/3569/4313/4318/5328/6696/7076/7124	22
WP691	Tamoxifen metabolism	12/644	17/6049	7.20259859877843e-09	4.9800824597268e-07	4.03995380051783e-07	1545/1557/1558/1559/1565/1576/2326/2328/6783/6822/54657/7364	12
WP619	Type II interferon signaling	17/644	34/6049	9.68573434801825e-09	5.85986928055104e-07	4.75365646290896e-07	4261/3627/4283/2633/3383/3433/3458/3553/3659/9636/4843/5698/8651/9021/6688/6772/6890	17
WP5088	Prostaglandin signaling	15/644	28/6049	2.17793610969857e-08	1.12252326163426e-06	9.10615869050843e-07	834/6347/6348/2919/3627/4283/3458/3605/3552/3553/3569/4318/114548/9536/7124	15
WP2882	Nuclear receptors meta-pathway	59/644	268/6049	2.31926293726086e-08	1.12252326163426e-06	9.10615869050843e-07	5243/1244/64240/64241/51129/335/345/8553/330/874/6347/6364/1545/1555/1557/1559/1576/1551/1907/9982/2938/2939/1839/3082/3458/3589/3553/3726/23764/4199/8431/9971/9970/5142/5743/6286/6319/5272/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/23657/8140/5552/27286/2040/6822/7042/7056/7124/54657/7364	59
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	23/644	63/6049	4.36508336158256e-08	1.92063667909633e-06	1.55806324772277e-06	59272/6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/3433/8519/3586/3569/3902/5196/6772/7124	23
WP2865	IL1 and megakaryocytes in obesity	13/644	23/6049	8.35886891142744e-08	3.3714104609424e-06	2.73496324908985e-06	6347/1232/2205/1839/3383/3458/3553/4318/114548/7941/6280/7076/7097	13
WP455	GPCRs, class A rhodopsin-like	33/644	118/6049	1.03959016971935e-07	3.87047417033972e-06	3.13981484457746e-06	51554/134/27202/1230/2826/1232/1234/1237/10803/3577/3579/57105/1909/2151/2867/2357/2358/29909/2828/8111/8843/3274/3352/4543/64106/4888/53829/5031/5724/5737/5739/6752/56670	33
WP2328	Allograft rejection	25/644	76/6049	1.2255798775683e-07	4.23700471959325e-06	3.43715258896973e-06	5243/717/720/721/958/1604/941/1493/6373/4283/50943/10578/3002/3119/3134/3458/3586/3605/3552/3553/3559/120892/5551/6772/7124	25
WP5198	Inflammatory bowel disease signaling	16/644	35/6049	1.32428960623345e-07	4.27304112944659e-06	3.46638612719351e-06	50943/3458/3586/3594/3595/8807/3552/50615/51561/3569/4094/64127/6772/30009/7097/7124	16
WP129	Matrix metalloproteinases	13/644	24/6049	1.64748198673487e-07	4.98363300987299e-06	4.04283408586913e-06	4312/4319/4321/4322/4327/4313/10893/64386/4314/4316/4318/7076/7124	13
WP1533	Vitamin B12 metabolism	16/644	37/6049	3.42110819330632e-07	9.72474896799528e-06	7.88893293836937e-06	335/338/875/6347/8029/3383/3458/3553/3569/3949/6288/6289/5054/6648/6947/7124	16
WP3617	Photodynamic therapy-induced NF-kB survival signaling	15/644	33/6049	3.61664217818006e-07	9.72474896799528e-06	7.88893293836937e-06	597/330/1437/2920/3383/3552/3553/3569/4312/4313/4314/4318/5743/6401/7124	15
WP4754	IL-18 signaling pathway	51/644	239/6049	6.11044506339911e-07	1.5061711574932e-05	1.22183958622219e-05	321/467/330/6362/6347/6364/6348/6351/1051/9076/24146/6900/1277/1278/1281/2920/2921/338442/3383/3458/3586/8807/3553/3559/3569/3659/3801/4312/4322/4313/4314/4318/4688/64332/4843/8431/7941/5743/6004/8698/9021/6696/30009/7052/7076/7124/7127/4982/79931/7185/80149	51
WP530	Cytokines and inflammatory response	11/644	19/6049	6.22384775823638e-07	1.5061711574932e-05	1.22183958622219e-05	1437/1440/2919/2920/3458/3586/3589/3552/3553/3569/7124	11
WP15	Selenium micronutrient network	20/644	59/6049	1.32217445004769e-06	3.04729730391945e-05	2.47203543793378e-05	240/335/338/875/6347/1734/3383/3458/3553/3569/8564/8942/3949/5743/6288/6289/5054/6648/7124/7498	20
WP2877	Vitamin D receptor pathway	35/644	143/6049	1.44555514083854e-06	3.18022130984478e-05	2.57986635183145e-05	5243/240/248/768/838/875/958/634/1493/1594/1555/1559/1565/1576/168002/1673/50486/3091/3488/3726/5653/639/6273/6279/6280/10568/6696/6699/79689/412/6822/7042/7056/4982/54210	35
WP4462	Platelet-mediated interactions with vascular and circulating cells	10/644	17/6049	1.69596720492125e-06	3.56890490079081e-05	2.89517513700516e-05	6347/958/3383/3553/5196/6401/6403/7042/7043/7097	10
WP24	Peptide GPCRs	16/644	41/6049	1.81802091283246e-06	3.66634217421212e-05	2.97421842318643e-05	728/1230/2826/1232/1234/1237/10803/3577/3579/10663/1909/2357/2358/4888/6752/7253	16
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/644	24/6049	1.24451263347167e-05	0.000231696483245368	0.000187957347217317	6348/6351/1230/1232/1234/1437/3458/3594/3595/7042/7043	11
WP702	Metapathway biotransformation Phase I and II	30/644	125/6049	1.24465052983049e-05	0.000231696483245368	0.000187957347217317	50515/9435/9469/1545/56603/1594/1555/1562/1557/1558/1559/1565/1576/1551/8529/260293/9420/2326/2327/2328/92292/2938/2939/9027/4837/6783/6822/54657/79799/7364	30
WP43	Oxidation by cytochrome P450	14/644	38/6049	1.76750401996106e-05	0.000316841461355983	0.000257028849686346	1545/56603/1594/1555/1562/1557/1558/1559/1565/1576/1551/8529/260293/9420	14
WP5218	Extrafollicular B cell activation by SARS-CoV-2	19/644	65/6049	2.75796154761381e-05	0.000476733353230388	0.000386736713255621	720/958/941/83416/29851/3433/8519/3458/3586/3569/9636/3687/3689/4094/639/6402/57823/30009/7124	19
WP5090	Complement system in neuronal development and plasticity	23/644	94/6049	9.30120268703595e-05	0.00155233865535359	0.00125929168866222	715/717/720/721/722/725/728/27202/843/1604/629/3426/5199/10584/2219/8547/3458/3687/3689/5648/710/7042/7043	23
WP2876	Pregnane X receptor pathway	11/644	29/6049	0.000104642525857193	0.00168823275049604	0.00136953200507835	5243/1244/1555/1557/1559/1576/1551/2939/27286/6822/54657	11
WP430	Statin inhibition of cholesterol production	10/644	25/6049	0.000128677210726652	0.00194624281224061	0.00157883551319215	64240/64241/335/337/338/341/345/3949/4547/6713	10
WP5092	Interactions of natural killer cells in pancreatic cancer	10/644	25/6049	0.000128677210726652	0.00194624281224061	0.00157883551319215	6347/6348/6351/1437/2214/3002/3458/4277/5551/7124	10
WP2289	Drug induction of bile acid pathway	7/644	13/6049	0.000144886074231483	0.00212499575539508	0.00172384388160584	5243/1244/1576/9971/9970/200931/6822	7
WP2431	Spinal cord injury	23/644	98/6049	0.000183023918596028	0.00255047048963648	0.00206899846157984	301/63827/6347/50515/1282/2919/3627/2920/2212/3383/3458/3552/3553/3569/10288/11025/4321/4318/4843/5320/5743/6403/7124	23
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	18/644	68/6049	0.000184434849457184	0.00255047048963648	0.00206899846157984	6347/958/1594/1673/10964/3458/3569/9636/5600/6300/64127/4939/91543/6258/6772/7097/51311/7124	18
WP1604	Codeine and morphine metabolism	6/644	10/6049	0.000205160911796713	0.00275827448082248	0.00223757368713959	5243/1244/1558/1565/1576/7364	6
WP2911	miRNA targets in ECM and membrane receptors	9/644	22/6049	0.000230139504700222	0.00301047352094344	0.00244216316509766	1278/1281/1282/1284/1290/50509/1291/1293/7058	9
WP545	Complement activation	8/644	18/6049	0.0002614811951007	0.00329696635272478	0.00267457253059231	715/717/720/721/1604/629/5199/5648	8
WP2875	Constitutive androstane receptor pathway	10/644	27/6049	0.000272476558076428	0.00329696635272478	0.00267457253059231	5243/1244/1555/1557/1559/1576/2939/9970/6822/54657	10
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	10/644	27/6049	0.000272476558076428	0.00329696635272478	0.00267457253059231	59272/6347/2939/3553/3569/4312/4314/5593/23657/7124	10
WP117	GPCRs, other	12/644	37/6049	0.000287412898324531	0.00339287421436764	0.00275237512387805	27202/1234/3577/3579/1909/29933/11245/53831/59340/53829/5737/6752	12
WP176	Folate metabolism	14/644	48/6049	0.000320452547125183	0.00356157871120074	0.00288923196885141	335/338/875/6347/3383/3458/3553/3569/3949/6288/6289/5054/6648/7124	14
WP558	Complement and coagulation cascades	14/644	48/6049	0.000320452547125183	0.00356157871120074	0.00288923196885141	715/717/721/728/1604/629/3426/5648/5328/5329/5054/710/7056/7450	14
WP2880	Glucocorticoid receptor pathway	17/644	65/6049	0.000323779882836431	0.00356157871120074	0.00288923196885141	51129/8553/330/6347/6364/1907/9982/3589/8972/9970/5142/5743/6286/5272/5552/2040/7056	17
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10/644	28/6049	0.000383981943726466	0.00412993912808021	0.00335029859672449	6347/29126/941/1493/3627/3559/8651/7042/7043/51311	10
WP5174	Ulcerative colitis signaling	7/644	15/6049	0.00044862078887941	0.00472027090907901	0.00382918888448558	50943/3458/3586/4094/64127/7097/7124	7
WP4329	miRNAs involvement in the immune response in sepsis	12/644	39/6049	0.00049680010582335	0.00500940106705211	0.0040637377077217	6348/6351/3002/3383/3586/3552/3569/3659/3934/407008/51311/7124	12
WP5097	CCL18 signaling pathway	12/644	39/6049	0.00049680010582335	0.00500940106705211	0.0040637377077217	467/1237/1278/1437/3091/440823/4313/4318/6615/6772/7291/652995	12
WP2848	Pluripotent stem cell differentiation pathway	11/644	34/6049	0.000526069186895815	0.00519627523382805	0.00421533419360127	3577/22943/2255/3082/3589/3569/3624/6469/7043/7472/7474	11
WP5094	Orexin receptor pathway	24/644	112/6049	0.000571109647818116	0.00552834139087937	0.00448471365549805	8553/2920/1734/1846/1959/1960/1839/3091/3383/3586/3553/3569/3726/3949/23764/4322/4314/64106/8013/5069/6401/6696/3371/7124	24
WP167	Eicosanoid synthesis	8/644	20/6049	0.000620134508862797	0.00588519808410968	0.00477420375244217	246/240/1800/5320/80339/5730/9536/5743	8
WP4969	RAS and bradykinin pathways in COVID-19	9/644	25/6049	0.000704659646431504	0.00655875517063169	0.00532060826151723	1636/59272/183/1576/3552/3553/5054/710/7124	9
WP299	Nuclear receptors in lipid metabolism and toxicity	9/644	26/6049	0.000977448140632355	0.00876083148270482	0.00710698160732687	5243/1244/64240/1594/1555/1559/1576/9971/9970	9
WP453	Inflammatory response pathway	9/644	26/6049	0.000977448140632355	0.00876083148270482	0.00710698160732687	958/941/1277/1278/1281/3458/3559/3568/3918	9
WP75	Toll-like receptor signaling pathway	19/644	84/6049	0.00105727042406331	0.00930397973175713	0.00754759556316966	6348/6351/958/941/3627/6373/4283/3553/3569/23643/1326/5600/6300/8503/6696/6772/7097/51311/7124	19
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	11/644	37/6049	0.00116758211097737	0.0100912453877329	0.0081862429961383	84674/834/838/50506/3553/4210/91662/114548/199713/64127/639	11
WP4724	Omega-9 fatty acid synthesis	6/644	13/6049	0.00126506454404491	0.0107419515669779	0.00871411034032784	2180/2182/54898/3992/9415/6319	6
WP465	Tryptophan metabolism	10/644	33/6049	0.00165531373974875	0.0136732175382751	0.0110920185771566	8854/316/1545/1562/1576/9420/3620/8942/4129/6999	10
WP5033	Genes associated with the development of rheumatoid arthritis	7/644	18/6049	0.00166677651809551	0.0136732175382751	0.0110920185771566	958/4261/1493/3559/23569/6583/7185	7
WP697	Estrogen metabolism	6/644	14/6049	0.0020163969719839	0.0162656022406701	0.0131950187815788	1545/1576/2938/412/6783/7364	6
WP716	Vitamin A and carotenoid metabolism	10/644	34/6049	0.00212583230343747	0.0168672595879301	0.0136830966209176	64240/64241/8854/1381/1382/56603/9227/29881/5948/6258	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	6/644	15/6049	0.00306158109405355	0.0239000846697083	0.0193882809521557	335/338/3949/9388/4547/255738	6
WP5044	Kynurenine pathway and links to cell senescence	7/644	20/6049	0.00335831026527153	0.0258003518792289	0.0209298200325193	3620/169355/3458/8564/8942/6999/7124	7
WP3942	PPAR signaling pathway	13/644	54/6049	0.00356549307218509	0.0269640413583998	0.0218738308540303	2180/2182/51129/335/345/126129/2172/9415/4199/4312/4973/6258/6319	13
WP4478	LTF danger signal response pathway	6/644	16/6049	0.00446358975895772	0.0322444394527692	0.0261574073855653	3552/3553/3569/7097/7124/54210	6
WP4493	Cells and molecules involved in local acute inflammatory response 	6/644	16/6049	0.00446358975895772	0.0322444394527692	0.0261574073855653	3383/3552/3569/3689/6403/7124	6
WP516	Hypertrophy model	6/644	16/6049	0.00446358975895772	0.0322444394527692	0.0261574073855653	467/11072/1839/3458/3552/8013	6
WP4538	Regulatory circuits of the STAT3 signaling pathway	16/644	75/6049	0.00476853032364441	0.0339311073561648	0.0275256699518257	1271/1439/1441/2151/3595/3601/50615/3559/3568/3575/5600/6300/9180/5159/11122/9021	16
WP2884	NRF2 pathway	22/644	116/6049	0.00483728596606482	0.0339311073561648	0.0275256699518257	1244/874/2938/2939/1839/3082/23764/4199/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/23657/7042/54657/7364	22
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/644	22/6049	0.00611580896451728	0.0422864505546623	0.0343037104325556	2919/2920/3553/5354/6469/55553/7124	7
WP3967	miR-509-3p alteration of YAP1/ECM axis	6/644	17/6049	0.00628721720127541	0.0428593397946098	0.0347684509425608	1277/1281/1909/6678/7058/7291	6
WP4239	Epithelial to mesenchymal transition in colorectal cancer	24/644	135/6049	0.00773081261080259	0.051968240328173	0.042157793915634	9076/24146/51208/1282/1284/94234/11211/3091/3678/5600/6300/4313/4318/4854/4855/8503/6615/6678/7042/7043/7291/7480/7472/7474	24
WP3893	Development and heterogeneity of the ILC family	7/644	23/6049	0.00800097809966531	0.0530475808251782	0.0430333789643138	3458/3605/3553/51561/3569/30009/7124	7
WP4723	Omega-3 / omega-6 fatty acid synthesis	5/644	13/6049	0.00836215771312109	0.0546930315290623	0.0443682052204007	2180/2182/54898/3992/9415	5
WP497	Urea cycle and metabolism of amino groups	6/644	18/6049	0.00859743754286537	0.054752102246669	0.0444161247020607	384/445/1373/2628/4942/5009	6
WP5149	Lipid metabolism in senescent cells	6/644	18/6049	0.00859743754286537	0.054752102246669	0.0444161247020607	240/84647/50487/283748/7941/5743	6
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	9/644	35/6049	0.00922728364524227	0.0580000686272371	0.0470509473639832	285/597/664/3091/4843/5743/5054/6515/7043	9
WP3929	Chemokine signaling pathway	26/644	152/6049	0.00947520895966034	0.0587948863650719	0.0476957212139448	6356/6361/6364/6370/10344/6348/6351/1230/2826/1232/1237/10803/3627/6373/2921/6374/4283/3579/10663/2268/2786/3055/4067/5196/8503/6772	26
WP4210	Tryptophan catabolism leading to NAD+ production	5/644	14/6049	0.0118875803470862	0.0719198610998716	0.0583429930192521	3620/8564/8942/10135/6999	5
WP5063	FOXP3 in COVID-19	5/644	14/6049	0.0118875803470862	0.0719198610998716	0.0583429930192521	941/50943/3559/3569/3575	5
WP4496	Signal transduction through IL1R	8/644	31/6049	0.013523558433858	0.08080743558009	0.0655527913687985	3552/3553/3557/3569/11213/7042/7043/7124	8
WP2374	Oncostatin M signaling pathway	13/644	64/6049	0.0156810643650629	0.0922279778922294	0.0748173896341922	6347/1051/3091/3726/3949/4312/4322/4314/5008/9180/5054/9021/6772	13
WP4389	Bile acids synthesis and enterohepatic circulation 	4/644	10/6049	0.0158159548864774	0.0922279778922294	0.0748173896341922	64240/64241/3949/6555	4
WP5109	Familial hyperlipidemia type 2	5/644	15/6049	0.0163005799736025	0.0939223893717098	0.0761919339618263	335/337/338/3949/255738	5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	10/644	45/6049	0.0177165353565598	0.100880036618529	0.0818361323590937	2180/2182/9023/54898/3992/9415/4597/6319/8435/6713	10
WP727	Monoamine transport	6/644	21/6049	0.0190675494917753	0.107310394814177	0.087052582135033	183/3553/6532/6999/7124/4982	6
WP5122	Prostaglandin and leukotriene metabolism in senescence 	7/644	27/6049	0.0199218555674954	0.110829633272044	0.0899074667474385	246/240/3488/5600/5730/9536/5743	7
WP4747	Netrin-UNC5B signaling pathway	10/644	46/6049	0.0205534061966326	0.113043734081479	0.0917035946333009	249/6347/1003/1277/3383/3586/3552/54538/6401/7124	10
WP247	Small ligand GPCRs	5/644	16/6049	0.0216810300711684	0.117905826454444	0.0956478322477327	4543/5724/5737/5739/8698	5
WP4136	Fibrin complement receptor 3 signaling pathway	8/644	35/6049	0.027633708919117	0.147142074084955	0.119364927432988	6347/3627/2921/3569/3689/23643/4843/7124	8
WP3287	Overview of nanoparticle effects	5/644	17/6049	0.0280951187669571	0.147142074084955	0.119364927432988	1001/1282/3569/5743/7124	5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	5/644	17/6049	0.0280951187669571	0.147142074084955	0.119364927432988	249/1594/5251/142680/6696	5
WP5130	Th17 cell differentiation pathway	12/644	62/6049	0.0282731671278942	0.147142074084955	0.119364927432988	50943/3091/3458/3605/3553/50615/51561/3559/3569/9021/6772/30009	12
WP4197	Immune response to tuberculosis	6/644	23/6049	0.0295445018682613	0.151819401520652	0.123159279615492	3437/8519/3659/8651/6772/6890	6
WP364	IL6 signaling pathway	9/644	42/6049	0.0297992626951693	0.151819401520652	0.123159279615492	183/3055/3569/3659/3726/639/9021/6772/7076	9
WP3611	Photodynamic therapy-induced AP-1 survival signaling	10/644	49/6049	0.0310381685391882	0.156484099718407	0.126943386678916	602/2252/1839/3458/3569/3726/5600/6300/4313/7124	10
WP4495	IL-10 anti-inflammatory signaling pathway 	4/644	12/6049	0.0313807946322943	0.156580459814747	0.12702155613506	3586/3552/3569/6772	4
WP2873	Aryl hydrocarbon receptor pathway	8/644	36/6049	0.0323365335246991	0.159702879856677	0.129554532811093	1545/2939/3458/3553/3726/8140/7124/54657	8
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	38/644	265/6049	0.0330390300120003	0.161524146725335	0.131031985055567	285/1277/1278/1281/1282/1284/1290/50509/84699/9586/1440/1441/2255/2252/2254/2786/3082/3091/3559/3575/3678/3687/3689/3918/10319/23566/4843/5008/9180/5159/5209/5228/6514/6515/6696/7058/3371/7450	38
WP236	Adipogenesis	19/644	115/6049	0.0336925521756243	0.163071952530022	0.13228759959482	183/1051/1271/56603/1959/3091/3569/10135/5008/80339/6258/6319/5054/8651/9021/6772/7124/7291/7480	19
WP474	Endochondral ossification	11/644	57/6049	0.0355499320197851	0.165783242587084	0.134487058471036	9507/249/50515/4256/4322/4318/5328/55553/6696/6772/7042	11
WP4808	Endochondral ossification with skeletal dysplasias	11/644	57/6049	0.0355499320197851	0.165783242587084	0.134487058471036	9507/249/50515/4256/4322/4318/5328/55553/6696/6772/7042	11
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	6/644	24/6049	0.0359653728752972	0.165783242587084	0.134487058471036	246/240/8529/57105/1800/2358	6
WP5036	Angiotensin II receptor type 1 pathway	6/644	24/6049	0.0359653728752972	0.165783242587084	0.134487058471036	59272/183/1277/1278/3091/3589	6
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	6/644	24/6049	0.0359653728752972	0.165783242587084	0.134487058471036	1636/59272/183/3569/114548/7124	6
WP4298	Acute viral myocarditis	14/644	79/6049	0.0375511835490485	0.17146012111075	0.139092268756654	834/1232/1234/1604/941/3458/3586/3569/3689/4318/64127/8651/6772/7124	14
WP5108	Familial  hyperlipidemia type 1	4/644	13/6049	0.0416112999297044	0.186480270055342	0.151276948087522	51129/335/337/3949	4
WP554	ACE inhibitor pathway	4/644	13/6049	0.0416112999297044	0.186480270055342	0.151276948087522	1636/59272/183/1215	4
WP2895	Differentiation of white and brown adipocyte	5/644	19/6049	0.0442143733388504	0.194543242690942	0.157817811056375	1051/253738/3224/27129/51316	5
WP5066	FOXA2 pathway	5/644	19/6049	0.0442143733388504	0.194543242690942	0.157817811056375	1244/338/2938/2939/4547	5
WP3937	Microglia pathogen phagocytosis pathway	8/644	39/6049	0.0496253500562915	0.21638440925446	0.175535851787546	2207/2209/3055/3689/4067/4688/8503/54210	8
WP2849	Hematopoietic stem cell differentiation	9/644	46/6049	0.0503739356223031	0.217687364653524	0.176592838224803	4261/1437/1440/3552/3553/3569/4778/6688/23650	9
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	6/644	26/6049	0.0513217256506558	0.219443909128576	0.178017786222181	8529/5730/9536/5737/5739/5743	6
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	20/644	129/6049	0.0534707947390028	0.219443909128576	0.178017786222181	116/8553/720/721/1051/2328/2538/3091/3586/3552/3553/3557/3569/3764/5354/6507/6532/6752/7124/11076	20
WP12	Osteoclast signaling	4/644	14/6049	0.053500787762752	0.219443909128576	0.178017786222181	1513/8111/6696/4982	4
WP2879	Farnesoid X receptor pathway	4/644	14/6049	0.053500787762752	0.219443909128576	0.178017786222181	1576/8431/9971/6822	4
WP3971	OSX and miRNAs in tooth development	4/644	14/6049	0.053500787762752	0.219443909128576	0.178017786222181	249/22943/4854/4855	4
WP5178	Disorders of fructose metabolism	4/644	14/6049	0.053500787762752	0.219443909128576	0.178017786222181	229/2538/3795/6514	4
WP98	Prostaglandin synthesis and regulation	8/644	41/6049	0.0639566759991874	0.260126312467283	0.211020257830136	301/1909/3290/5730/9536/5737/5739/5743	8
WP5087	Malignant pleural mesothelioma	50/644	381/6049	0.0655049680167808	0.264203371001016	0.214327658511046	72/285/467/834/6347/6351/29126/1001/1003/1282/1284/1437/1440/115908/1496/2919/3627/6374/22943/2255/2252/2254/8061/11211/1839/3082/3091/3620/3586/3553/3569/3689/3918/10319/4313/4314/4318/114548/5159/5228/5328/6401/6423/6425/8140/6678/6772/7480/7472/7474	50
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4/644	15/6049	0.0670281360497153	0.265914900393952	0.215716089271301	1051/2939/4094/23657	4
WP4842	Mammalian disorder of sexual development	4/644	15/6049	0.0670281360497153	0.265914900393952	0.215716089271301	84733/2254/5600/5730	4
WP4595	Urea cycle and associated pathways	5/644	22/6049	0.0769323385962446	0.302725625045385	0.245577768903716	445/1373/4843/4942/5009	5
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	11/644	65/6049	0.0799436282023012	0.312038032660595	0.253132201353636	22943/1959/94234/2619/3458/3488/5653/5650/4488/22822/7474	11
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	3/644	10/6049	0.0815956166697792	0.313052107185835	0.253954841192511	1116/4318/9021	3
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	7/644	36/6049	0.0816157607510156	0.313052107185835	0.253954841192511	684/8519/10581/10410/3726/5600/6300	7
WP3413	NOTCH1 regulation of endothelial cell calcification	4/644	16/6049	0.0821438380425642	0.313052107185835	0.253954841192511	249/2702/4256/55553	4
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/644	23/6049	0.09009562657624	0.340674087991407	0.276362407178762	285/2022/2200/4053/5054	5
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	9/644	52/6049	0.0957195021238956	0.356371069445888	0.289096148115085	1003/1277/1278/3082/4313/4318/6615/7042/7043	9
WP5222	2q13 copy number variation syndrome	9/644	52/6049	0.0957195021238956	0.356371069445888	0.289096148115085	1437/3552/3553/3557/51561/3569/8651/9021/6772	9
WP5111	Familial hyperlipidemia type 4	4/644	17/6049	0.0987742132042896	0.364936787716612	0.296044849539574	335/337/3949/4547	4
WP5083	Neuroinflammation and glutamatergic signaling	17/644	115/6049	0.10047885542593	0.368422469895075	0.298872512550811	2893/2898/2906/116443/3458/3586/3552/3553/3569/29968/6507/6515/9021/6772/7042/7043/7124	17
WP3871	Valproic acid pathway	3/644	11/6049	0.103644710951092	0.371585482224657	0.3014384185946	116285/1555/1559	3
WP4583	Biomarkers for urea cycle disorders	3/644	11/6049	0.103644710951092	0.371585482224657	0.3014384185946	445/2628/5009	3
WP4707	Aspirin and miRNAs	3/644	11/6049	0.103644710951092	0.371585482224657	0.3014384185946	283120/4597/5743	3
WP3927	BMP signaling in eyelid development	4/644	18/6049	0.116825637854067	0.415761828833591	0.33727525479541	2255/2296/3625/6469	4
WP4545	Oxysterols derived from cholesterol	6/644	32/6049	0.118076652448616	0.417146713760074	0.338398704289925	134526/9023/1576/9420/3605/3638	6
WP534	Glycolysis and gluconeogenesis	7/644	40/6049	0.126817721029027	0.435370553519446	0.353182288957707	229/2538/3099/3101/5313/6514/6515	7
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3/644	12/6049	0.127732683057358	0.435370553519446	0.353182288957707	55509/1437/6688	3
WP5110	Familial hyperlipidemia type 3	3/644	12/6049	0.127732683057358	0.435370553519446	0.353182288957707	335/337/3949	3
WP5112	Familial hyperlipidemia type 5	3/644	12/6049	0.127732683057358	0.435370553519446	0.353182288957707	335/337/3949	3
WP5188	Retinol metabolism	3/644	12/6049	0.127732683057358	0.435370553519446	0.353182288957707	316/1551/9227	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	6/644	33/6049	0.132099337384712	0.44501890095062	0.361009243267902	1636/183/1215/84699/9586/3283	6
WP3646	Hepatitis C and hepatocellular carcinoma	8/644	48/6049	0.132402317638201	0.44501890095062	0.361009243267902	330/1284/3577/3091/3569/4312/4843/5743	8
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	5/644	26/6049	0.135883056976779	0.451474675306842	0.36624631119933	2254/5600/6300/6615/6772	5
WP3599	Transcription factor regulation in adipogenesis	4/644	19/6049	0.136188641724791	0.451474675306842	0.36624631119933	1051/3569/7124/7291	4
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	8/644	49/6049	0.144422590043038	0.4755138338832	0.385747412001813	1051/1513/3726/4129/6696/7042/4982/7480	8
WP4008	NO/cGMP/PKG mediated neuroprotection	6/644	34/6049	0.146873404077986	0.477868820303306	0.387657829432651	2906/3458/3553/4843/5593/7124	6
WP4655	Cytosolic DNA-sensing pathway	9/644	57/6049	0.147112508729737	0.477868820303306	0.387657829432651	834/843/6351/9560/3627/3553/3569/9636/81030	9
WP3869	Cannabinoid receptor signaling	5/644	27/6049	0.153062588766277	0.488996338354583	0.396684719891822	1557/1559/1576/5600/6300	5
WP4917	Proximal tubule transport	7/644	42/6049	0.153312898181002	0.488996338354583	0.396684719891822	5243/1244/6514/142680/6519/340024/11136	7
WP1434	Osteopontin signaling	3/644	13/6049	0.153569097995654	0.488996338354583	0.396684719891822	4318/5328/6696	3
WP4787	Osteoblast differentiation and related diseases	14/644	98/6049	0.155242732873082	0.491094658239029	0.398386923712827	2255/2252/2254/11211/5600/6300/4854/4855/5288/8503/6772/7480/7472/7474	14
WP3645	NAD+ biosynthetic pathways	4/644	20/6049	0.15674176388898	0.492616972222508	0.399621858718998	952/3620/10135/6999	4
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	5/644	28/6049	0.171089896823816	0.534242000404689	0.433389008592756	9509/1277/1278/60681/4982	5
WP262	Ebstein-Barr virus LMP1 signaling	4/644	21/6049	0.178355098525064	0.540348520868147	0.438342753988297	6364/9260/7124/7185	4
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/644	21/6049	0.178355098525064	0.540348520868147	0.438342753988297	941/3101/3586/6515	4
WP4564	Neural crest cell migration during development	6/644	36/6049	0.178505827573416	0.540348520868147	0.438342753988297	2047/2151/4313/4318/8503/7291	6
WP3935	Leptin-insulin signaling overlap	3/644	14/6049	0.1808604553319	0.540348520868147	0.438342753988297	8503/8651/9021	3
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	3/644	14/6049	0.1808604553319	0.540348520868147	0.438342753988297	3589/3569/652995	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/644	14/6049	0.1808604553319	0.540348520868147	0.438342753988297	941/1493/8503	3
WP5061	Fatty acid transporters	3/644	14/6049	0.1808604553319	0.540348520868147	0.438342753988297	2180/2182/2172	3
WP4331	Neovascularisation processes	6/644	37/6049	0.195268994770416	0.579175713015414	0.469840236961178	3091/4318/4854/4855/7042/7043	6
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	7/644	45/6049	0.197333583711359	0.579175713015414	0.469840236961178	6356/3055/3559/3569/3575/4067/6772	7
WP5053	Development of ureteric collection system	8/644	53/6049	0.197446265800709	0.579175713015414	0.469840236961178	2296/80144/158326/341640/2674/80000/6469/7042	8
WP3591	Sleep regulation	4/644	22/6049	0.200893489620357	0.585737644435258	0.475163421866793	100/134/3569/5730	4
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	11/644	78/6049	0.203641917605091	0.590195737250684	0.478779926042855	467/22943/8061/11211/283120/5328/6423/6425/7480/7472/7474	11
WP272	Blood clotting cascade	3/644	15/6049	0.209318535152447	0.599468467537185	0.486302171360091	5328/5054/7450	3
WP698	Glucuronidation	3/644	15/6049	0.209318535152447	0.599468467537185	0.486302171360091	54657/79799/7364	3
WP4816	TGF-beta receptor signaling in skeletal dysplasias	8/644	54/6049	0.211814081268987	0.603047149024645	0.489205277481932	2022/2200/3458/3624/5054/6696/6772/7124	8
WP4357	NRF2-ARE regulation	4/644	23/6049	0.224219355524382	0.630942837638377	0.511834881337788	1051/2939/4094/23657	4
WP4585	Cancer immunotherapy by PD-1 blockade	4/644	23/6049	0.224219355524382	0.630942837638377	0.511834881337788	10538/29126/3458/80380	4
WP4241	Type 2 papillary renal cell carcinoma	5/644	31/6049	0.229486637387642	0.640959533841264	0.519960648374927	1513/112399/3091/7042/7043	5
WP4565	Neural crest cell migration in cancer	6/644	39/6049	0.230427601009049	0.640959533841264	0.519960648374927	2047/2151/4313/4318/8503/7291	6
WP4172	PI3K-Akt signaling pathway	34/644	281/6049	0.235280898126861	0.650719741105147	0.527878345872597	285/1277/1278/1282/1284/1291/1293/84699/9586/1440/1441/2255/2252/2254/2538/2786/3082/3559/3569/3575/3678/3918/10319/23566/5008/9180/5159/5228/8503/6696/7058/7097/3371/7450	34
WP3644	NAD+ metabolism	3/644	16/6049	0.238666542177804	0.652624894994674	0.52942384913661	952/10135/203447	3
WP4225	Pyrimidine metabolism and related diseases	3/644	16/6049	0.238666542177804	0.652624894994674	0.52942384913661	1373/5009/1890	3
WP3941	Oxidative damage response	6/644	40/6049	0.248711697476112	0.676272256058642	0.548607115071495	715/717/721/728/7124/7185	6
WP3298	Melatonin metabolism and effects	5/644	32/6049	0.250118116080054	0.676296543582905	0.548626817652074	1545/1557/1565/406938/4543	5
WP2324	AGE/RAGE pathway	9/644	65/6049	0.251515243481246	0.676296543582905	0.548626817652074	249/3091/3625/4322/4313/4316/4318/4843/6772	9
WP4830	GDNF/RET signaling axis	3/644	17/6049	0.268643469814986	0.718361543593664	0.582750882471589	2296/2674/26585	3
WP4900	Purinergic signaling	4/644	25/6049	0.272685403088512	0.725163379641978	0.588268683354627	134/5027/53829/5031	4
WP560	TGF-beta receptor signaling	7/644	50/6049	0.279694763744259	0.739739156569516	0.600092878208851	2022/3458/3624/5054/6696/6772/7124	7
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	6/644	42/6049	0.286401896676231	0.752025016523914	0.610059441416747	330/6347/3569/4318/7124/7185	6
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	8/644	59/6049	0.288852655155905	0.752025016523914	0.610059441416747	1437/1493/29851/3458/3586/3937/1326/7124	8
WP4846	SARS-CoV-2 and COVID-19 pathway	2/644	10/6049	0.289001349325306	0.752025016523914	0.610059441416747	59272/340024	2
WP3877	MYD88 distinct input-output pathway	3/644	18/6049	0.29900703620717	0.77390056430091	0.627805372953979	3552/7097/51311	3
WP2371	Parkinson's disease pathway	5/644	35/6049	0.314338928556828	0.809255539476088	0.656486116190911	120892/5600/6300/9627/9246	5
WP2197	Endothelin pathways	4/644	27/6049	0.32268829052018	0.815371373927027	0.661447417300524	1909/2769/4852/5739	4
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/644	19/6049	0.329535485172615	0.815371373927027	0.661447417300524	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/644	19/6049	0.329535485172615	0.815371373927027	0.661447417300524	2180/7124/7185	3
WP229	Irinotecan pathway	2/644	11/6049	0.330191713408465	0.815371373927027	0.661447417300524	1244/1576	2
WP3630	NAD metabolism, sirtuins and aging	2/644	11/6049	0.330191713408465	0.815371373927027	0.661447417300524	3091/10135	2
WP3930	EDA signaling in hair follicle development	2/644	11/6049	0.330191713408465	0.815371373927027	0.661447417300524	22943/6469	2
WP4271	Vitamin B12 disorders	2/644	11/6049	0.330191713408465	0.815371373927027	0.661447417300524	8029/6947	2
WP5052	Nephrogenesis	2/644	11/6049	0.330191713408465	0.815371373927027	0.661447417300524	8854/80000	2
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	7/644	53/6049	0.33268868581294	0.817367126565801	0.663066416287612	843/3627/3458/9636/5600/6300/7124	7
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4/644	28/6049	0.347954689469574	0.850018495065743	0.689553933578778	3082/7042/7043/7474	4
WP2018	RANKL/RANK signaling pathway	7/644	54/6049	0.350691286489699	0.850018495065743	0.689553933578778	1513/3383/4067/6688/6772/4982/7185	7
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	9/644	72/6049	0.357631773297498	0.850018495065743	0.689553933578778	22943/8061/11211/5328/6423/6425/7480/7472/7474	9
WP4963	p53 transcriptional gene network	10/644	81/6049	0.359684034009784	0.850018495065743	0.689553933578778	6347/126129/55332/3383/9636/4688/5268/5054/23657/7124	10
WP5098	T-cell activation SARS-CoV-2	10/644	81/6049	0.359684034009784	0.850018495065743	0.689553933578778	941/1493/29851/3458/3594/3595/3605/51561/3937/7124	10
WP3640	Imatinib and chronic myeloid leukemia	3/644	20/6049	0.360028494810903	0.850018495065743	0.689553933578778	5243/5159/11040	3
WP4224	Purine metabolism and related disorders	3/644	20/6049	0.360028494810903	0.850018495065743	0.689553933578778	100/316/7498	3
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3/644	20/6049	0.360028494810903	0.850018495065743	0.689553933578778	3569/4318/6696	3
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	2/644	12/6049	0.370683519478687	0.854337254417545	0.693057407346117	8061/7076	2
WP2881	Estrogen receptor pathway	2/644	12/6049	0.370683519478687	0.854337254417545	0.693057407346117	1545/8431	2
WP4211	Transcriptional cascade regulating adipogenesis	2/644	12/6049	0.370683519478687	0.854337254417545	0.693057407346117	1051/1959	2
WP4792	Purine metabolism	2/644	12/6049	0.370683519478687	0.854337254417545	0.693057407346117	100/7498	2
WP5171	Leukotriene metabolic pathway	2/644	12/6049	0.370683519478687	0.854337254417545	0.693057407346117	240/1800	2
WP4018	Clear cell renal cell carcinoma pathways	10/644	83/6049	0.389411734122093	0.889450431325995	0.721541998444098	229/3091/3099/3101/4199/5159/5313/29968/7042/7043	10
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	3/644	21/6049	0.390307394191877	0.889450431325995	0.721541998444098	5600/6300/7124	3
WP306	Focal adhesion	21/644	183/6049	0.391431698083547	0.889450431325995	0.721541998444098	330/1277/1278/1282/1284/1290/50509/2268/2318/3055/3082/3678/3918/10319/5159/5228/8503/6696/7058/3371/7450	21
WP2839	Hair follicle development: organogenesis - part 2 of 3	4/644	30/6049	0.398454704263412	0.896986404016238	0.727655347320698	3624/6469/6615/7474	4
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	4/644	30/6049	0.398454704263412	0.896986404016238	0.727655347320698	59272/4939/6772/7097	4
WP2828	Bladder cancer	5/644	39/6049	0.40239539407172	0.898266481982766	0.728693775075189	1839/4312/4313/4318/1890	5
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/644	13/6049	0.410158868839238	0.898266481982766	0.728693775075189	4312/5743	2
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	2/644	13/6049	0.410158868839238	0.898266481982766	0.728693775075189	249/7124	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/644	13/6049	0.410158868839238	0.898266481982766	0.728693775075189	1244/9420	2
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	2/644	13/6049	0.410158868839238	0.898266481982766	0.728693775075189	56624/3091	2
WP692	Sulfation biotransformation reaction	2/644	13/6049	0.410158868839238	0.898266481982766	0.728693775075189	6783/6822	2
WP357	Fatty acid biosynthesis	3/644	22/6049	0.420214852808433	0.912035824032652	0.73986377199691	2180/2182/6319	3
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	3/644	22/6049	0.420214852808433	0.912035824032652	0.73986377199691	1244/5600/6300	3
WP2406	Cardiac progenitor differentiation	4/644	31/6049	0.42348701046723	0.915034433330979	0.742296310640398	290/22943/3624/7070	4
WP69	T-cell receptor signaling pathway	10/644	86/6049	0.434220959825465	0.934057531357889	0.75772827141473	1234/29851/3601/3605/3552/3553/3569/3937/1326/3604	10
WP3925	Amino acid metabolism	9/644	77/6049	0.436564432544686	0.934943298016054	0.758446825054346	384/445/586/875/1373/3034/4942/5009/6999	9
WP5220	Metabolic reprogramming in pancreatic cancer	5/644	41/6049	0.446150350269094	0.942048752649799	0.764210928095639	3099/3949/4199/9122/8140	5
WP58	Monoamine GPCRs	2/644	14/6049	0.448375271090461	0.942048752649799	0.764210928095639	3274/3352	2
WP3845	Canonical and non-canonical Notch signaling	3/644	23/6049	0.44961417740104	0.942048752649799	0.764210928095639	4237/4854/4855	3
WP4483	Relationship between inflammation, COX-2 and EGFR	3/644	23/6049	0.44961417740104	0.942048752649799	0.764210928095639	4312/51365/5743	3
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3/644	23/6049	0.44961417740104	0.942048752649799	0.764210928095639	3553/3569/10135	3
WP4666	Hepatitis B infection	15/644	134/6049	0.459466732077904	0.958542665197006	0.777591157282478	843/84699/9586/1959/1960/3569/5600/6300/4318/8503/6772/7042/7043/7097/7124	15
WP3945	TYROBP causal network in microglia	7/644	61/6049	0.477253782524931	0.974332628818762	0.790400327423659	10261/3687/3689/4094/4688/5341/6696	7
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	6/644	52/6049	0.482725620275551	0.974332628818762	0.790400327423659	602/79092/3575/9021/7124/7185	6
WP395	IL-4 signaling pathway	6/644	52/6049	0.482725620275551	0.974332628818762	0.790400327423659	1051/9046/5600/8651/9021/6772	6
WP4746	Thyroid hormones production and peripheral downstream signaling effects	9/644	80/6049	0.483614982932126	0.974332628818762	0.790400327423659	1734/50506/405753/4852/5593/6469/5172/7038/7253	9
WP197	Cholesterol biosynthesis pathway	2/644	15/6049	0.485153230465541	0.974332628818762	0.790400327423659	4597/6713	2
WP2855	Dopaminergic neurogenesis	2/644	15/6049	0.485153230465541	0.974332628818762	0.790400327423659	4929/6469	2
WP4159	GABA receptor signaling	2/644	15/6049	0.485153230465541	0.974332628818762	0.790400327423659	2557/2562	2
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/644	15/6049	0.485153230465541	0.974332628818762	0.790400327423659	2254/5600	2
WP5182	Pro-survival signaling of neuroprotectin D1	2/644	15/6049	0.485153230465541	0.974332628818762	0.790400327423659	330/7124	2
WP5205	Clock-controlled autophagy in bone metabolism	8/644	71/6049	0.488959605394644	0.977919210789288	0.793309842593311	8553/115908/1513/22943/3569/4982/7480/7474	8
WP1591	Heart development	4/644	34/6049	0.496682738671612	0.989277553568149	0.802523983212091	8553/2255/2296/6469	4
WP4673	Male infertility	11/644	100/6049	0.502332350485367	0.99237385599282	0.80503577269535	5243/338/56603/2346/4313/4318/4843/29968/6648/7124/10537	11
WP205	IL-7 signaling pathway	3/644	25/6049	0.506438724029393	0.99237385599282	0.80503577269535	3559/3575/6772	3
WP3613	Photodynamic therapy-induced unfolded protein response	3/644	25/6049	0.506438724029393	0.99237385599282	0.80503577269535	467/121506/6783	3
WP4950	16p11.2 distal deletion syndrome	3/644	25/6049	0.506438724029393	0.99237385599282	0.80503577269535	8519/5350/7185	3
WP2267	Synaptic vesicle pathway	5/644	44/6049	0.510067420723428	0.995454159798948	0.807534583742949	22999/246213/6507/6581/6532	5
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	2/644	16/6049	0.520365614506646	0.999432370719113	0.810761797038341	3949/6319	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/644	16/6049	0.520365614506646	0.999432370719113	0.810761797038341	2180/2182	2
WP4558	Overview of interferons-mediated signaling pathway	2/644	16/6049	0.520365614506646	0.999432370719113	0.810761797038341	3458/6772	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/644	16/6049	0.520365614506646	0.999432370719113	0.810761797038341	3569/64386	2
WP2858	Ectoderm differentiation	13/644	121/6049	0.53034189348913	0.999999165026057	0.811221593202956	398/6347/1496/54898/57476/9687/152789/3801/3853/4061/6469/6781/4982	13
WP3594	Circadian rhythm genes	17/644	159/6049	0.531499422655777	0.999999165026057	0.811221593202956	100/134/56938/8553/1960/50865/3569/4543/4547/10135/4843/5551/5593/60675/5730/5054/6532	17
WP3851	TLR4 signaling and tolerance	3/644	26/6049	0.533683963216661	0.999999165026057	0.811221593202956	3569/11213/7124	3
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	3/644	26/6049	0.533683963216661	0.999999165026057	0.811221593202956	2557/2562/8503	3
WP4658	Small cell lung cancer	10/644	93/6049	0.536913820097346	0.999999165026057	0.811221593202956	330/1282/1284/3918/10319/4843/8503/5743/6258/7185	10
WP254	Apoptosis	9/644	84/6049	0.544716022005093	0.999999165026057	0.811221593202956	330/834/843/3002/8739/3659/5551/7124/7185	9
WP3303	RAC1/PAK1/p38/MMP2 pathway	7/644	65/6049	0.546876825436321	0.999999165026057	0.811221593202956	285/9046/5600/6300/4313/4843/79931	7
WP100	Glutathione metabolism	2/644	17/6049	0.553928567132201	0.999999165026057	0.811221593202956	290/2938	2
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	2/644	17/6049	0.553928567132201	0.999999165026057	0.811221593202956	3371/7472	2
WP3874	Canonical and non-canonical TGF-B signaling	2/644	17/6049	0.553928567132201	0.999999165026057	0.811221593202956	26585/4017	2
WP4912	SARS coronavirus and innate immunity	2/644	17/6049	0.553928567132201	0.999999165026057	0.811221593202956	59272/6772	2
WP5074	Kallmann syndrome	2/644	17/6049	0.553928567132201	0.999999165026057	0.811221593202956	60675/9723	2
WP2643	Nanoparticle-mediated activation of receptor signaling	3/644	27/6049	0.560058422303721	0.999999165026057	0.811221593202956	1277/5600/6300	3
WP286	IL-3 signaling pathway	5/644	47/6049	0.570788050191796	0.999999165026057	0.811221593202956	1232/1439/3055/3568/4067	5
WP4150	Wnt signaling in kidney disease	3/644	28/6049	0.585510870243819	0.999999165026057	0.811221593202956	7480/7472/7474	3
WP4561	Cell migration and invasion through p75NTR	3/644	28/6049	0.585510870243819	0.999999165026057	0.811221593202956	4313/4318/7291	3
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	2/644	18/6049	0.58579375849783	0.999999165026057	0.811221593202956	6615/3371	2
WP4760	PKC-gamma calcium signaling pathway in ataxia	2/644	18/6049	0.58579375849783	0.999999165026057	0.811221593202956	2769/2893	2
WP4784	Proteoglycan biosynthesis	2/644	18/6049	0.58579375849783	0.999999165026057	0.811221593202956	9469/55790	2
WP5193	Cholesterol synthesis disorders	2/644	18/6049	0.58579375849783	0.999999165026057	0.811221593202956	4597/6713	2
WP399	Wnt signaling pathway and pluripotency	9/644	87/6049	0.588654533118688	0.999999165026057	0.811221593202956	8061/11211/3949/120892/4316/5328/7480/7472/7474	9
WP127	IL-5 signaling pathway	4/644	39/6049	0.608564817406453	0.999999165026057	0.811221593202956	1439/3568/4067/6772	4
WP408	Oxidative stress response	3/644	29/6049	0.610003075459515	0.999999165026057	0.811221593202956	3726/6648/7498	3
WP4698	Vitamin D-sensitive calcium signaling in depression	3/644	29/6049	0.610003075459515	0.999999165026057	0.811221593202956	775/1594/2906	3
WP1584	Type II diabetes mellitus	2/644	19/6049	0.615941790653737	0.999999165026057	0.811221593202956	6514/7124	2
WP325	Triacylglyceride synthesis	2/644	19/6049	0.615941790653737	0.999999165026057	0.811221593202956	56895/2819	2
WP4722	Glycerolipids and glycerophospholipids	2/644	19/6049	0.615941790653737	0.999999165026057	0.811221593202956	56895/80339	2
WP4657	22q11.2 copy number variation syndrome	9/644	90/6049	0.630517981573676	0.999999165026057	0.811221593202956	8854/9076/56603/2255/2296/4942/5625/6469/7450	9
WP4149	White fat cell differentiation	3/644	30/6049	0.63350845003686	0.999999165026057	0.811221593202956	1051/1959/7480	3
WP4313	Ferroptosis	6/644	61/6049	0.643530113714502	0.999999165026057	0.811221593202956	2180/2182/246/875/1803/23657	6
WP2878	PPAR-alpha pathway	2/644	20/6049	0.644376601302941	0.999999165026057	0.811221593202956	335/345	2
WP3580	Methionine de novo and salvage pathway	2/644	20/6049	0.644376601302941	0.999999165026057	0.811221593202956	51074/259307	2
WP2332	Interleukin-11 signaling pathway	4/644	41/6049	0.64880421622896	0.999999165026057	0.811221593202956	3383/3589/9021/6772	4
WP382	MAPK signaling pathway	21/644	210/6049	0.65527973329923	0.999999165026057	0.811221593202956	775/994/1846/2255/2252/2254/2318/3310/3552/3553/120892/1326/5600/6300/22808/5159/283748/115727/7042/7043/7124	21
WP4844	Influence of laminopathies on Wnt signaling	3/644	31/6049	0.656010747133606	0.999999165026057	0.811221593202956	1051/6696/7480	3
WP2359	Parkin-ubiquitin proteasomal system pathway	6/644	62/6049	0.659447276108293	0.999999165026057	0.811221593202956	834/3310/9627/10381/84617/9246	6
WP1423	Ganglio sphingolipid metabolism	1/644	10/6049	0.675857661453139	0.999999165026057	0.811221593202956	6482	1
WP2333	Trans-sulfuration pathway	1/644	10/6049	0.675857661453139	0.999999165026057	0.811221593202956	875	1
WP2436	Dopamine metabolism	1/644	10/6049	0.675857661453139	0.999999165026057	0.811221593202956	4129	1
WP3656	Interleukin-1 induced activation of NF-kB	1/644	10/6049	0.675857661453139	0.999999165026057	0.811221593202956	3552	1
WP5050	TCA cycle in senescence	1/644	10/6049	0.675857661453139	0.999999165026057	0.811221593202956	4199	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/644	10/6049	0.675857661453139	0.999999165026057	0.811221593202956	629	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/644	10/6049	0.675857661453139	0.999999165026057	0.811221593202956	51311	1
WP4823	Genes controlling nephrogenesis	3/644	32/6049	0.677502824901253	0.999999165026057	0.811221593202956	2296/5159/6469	3
WP710	DNA damage response (only ATM dependent)	10/644	104/6049	0.681779039539448	0.999999165026057	0.811221593202956	8061/2538/3949/5288/8503/5328/6648/7480/7472/7474	10
WP2586	Aryl hydrocarbon receptor pathway	4/644	43/6049	0.686202687842007	0.999999165026057	0.811221593202956	1545/135112/5743/7124	4
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	4/644	43/6049	0.686202687842007	0.999999165026057	0.811221593202956	775/2906/116443/8503	4
WP4482	Vitamin D in inflammatory diseases	2/644	22/6049	0.696211315923147	0.999999165026057	0.811221593202956	3569/7124	2
WP3915	Angiopoietin-like protein 8 regulatory pathway	12/644	126/6049	0.702876230649989	0.999999165026057	0.811221593202956	64240/64241/1555/1576/1734/2538/1326/5600/6300/5288/8503/6319	12
WP410	Exercise-induced circadian regulation	4/644	44/6049	0.703816214553865	0.999999165026057	0.811221593202956	1051/50486/2674/10381	4
WP3679	Cell-type dependent selectivity of CCK2R signaling	1/644	11/6049	0.710424256257606	0.999999165026057	0.811221593202956	952	1
WP4788	Autosomal recessive osteopetrosis pathways	1/644	11/6049	0.710424256257606	0.999999165026057	0.811221593202956	29887	1
WP4919	Neuroinflammation	1/644	11/6049	0.710424256257606	0.999999165026057	0.811221593202956	4843	1
WP4947	Nitric oxide metabolism in cystic fibrosis	1/644	11/6049	0.710424256257606	0.999999165026057	0.811221593202956	4843	1
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	1/644	11/6049	0.710424256257606	0.999999165026057	0.811221593202956	2358	1
WP170	Nuclear receptors	3/644	34/6049	0.717466396834852	0.999999165026057	0.811221593202956	9970/4929/6258	3
WP2361	Gastric cancer network 1	2/644	23/6049	0.719696757687157	0.999999165026057	0.811221593202956	11082/6286	2
WP34	Ovarian infertility	2/644	23/6049	0.719696757687157	0.999999165026057	0.811221593202956	1051/2701	2
WP5064	7-oxo-C and 7-beta-HC pathways	2/644	23/6049	0.719696757687157	0.999999165026057	0.811221593202956	134526/3290	2
WP428	Wnt signaling	9/644	98/6049	0.729932345015686	0.999999165026057	0.811221593202956	22943/8061/11211/5328/6423/6425/7480/7472/7474	9
WP3527	Pre-implantation embryo	3/644	35/6049	0.735959092891106	0.999999165026057	0.811221593202956	366/55509/94234	3
WP2513	Nanoparticle triggered regulated necrosis	1/644	12/6049	0.741309777782963	0.999999165026057	0.811221593202956	7124	1
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1/644	12/6049	0.741309777782963	0.999999165026057	0.811221593202956	22943	1
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	1/644	12/6049	0.741309777782963	0.999999165026057	0.811221593202956	4597	1
WP4504	Cysteine and methionine catabolism	1/644	12/6049	0.741309777782963	0.999999165026057	0.811221593202956	875	1
WP5173	Disorders of galactose metabolism 	1/644	12/6049	0.741309777782963	0.999999165026057	0.811221593202956	6514	1
WP1539	Angiogenesis	2/644	24/6049	0.741633887884491	0.999999165026057	0.811221593202956	3091/4318	2
WP26	S1P receptor signal transduction	2/644	24/6049	0.741633887884491	0.999999165026057	0.811221593202956	6300/8877	2
WP289	Myometrial relaxation and contraction pathways	12/644	131/6049	0.752380661146476	0.999999165026057	0.811221593202956	133/467/2786/3488/3553/3569/23764/5142/10268/6004/5999/8490	12
WP1528	Physiological and pathological hypertrophy of the heart	2/644	25/6049	0.762085641263195	0.999999165026057	0.811221593202956	183/5600	2
WP581	EPO receptor signaling	2/644	25/6049	0.762085641263195	0.999999165026057	0.811221593202956	8651/6772	2
WP3931	Embryonic stem cell pluripotency pathways	8/644	91/6049	0.76725619963236	0.999999165026057	0.811221593202956	2255/2252/2254/6300/5159/7480/7472/7474	8
WP304	Kit receptor signaling pathway	5/644	59/6049	0.767688141304694	0.999999165026057	0.811221593202956	3726/4067/6615/8651/6772	5
WP5037	Riboflavin and CoQ disorders	1/644	13/6049	0.768905686861606	0.999999165026057	0.811221593202956	55065	1
WP2272	Pathogenic Escherichia coli infection	4/644	49/6049	0.781110519702468	0.999999165026057	0.811221593202956	9076/23643/10381/84617	4
WP1422	Sphingolipid pathway	2/644	26/6049	0.781119114433739	0.999999165026057	0.811221593202956	56624/8877	2
WP241	One-carbon metabolism	2/644	26/6049	0.781119114433739	0.999999165026057	0.811221593202956	2346/2745	2
WP4875	Disruption of postsynaptic signaling by CNV	2/644	26/6049	0.781119114433739	0.999999165026057	0.811221593202956	2906/9378	2
WP4758	Nephrotic syndrome	3/644	38/6049	0.785712671849834	0.999999165026057	0.811221593202956	8542/1493/8029	3
WP536	Calcium regulation in cardiac cells	11/644	125/6049	0.791365669978682	0.999999165026057	0.811221593202956	775/2701/2702/2709/10052/2786/3760/5350/6004/5999/8490	11
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/644	14/6049	0.793561872690156	0.999999165026057	0.811221593202956	283120	1
WP4584	Biomarkers for pyrimidine metabolism disorders	1/644	14/6049	0.793561872690156	0.999999165026057	0.811221593202956	1890	1
WP47	Hedgehog signaling pathway	1/644	14/6049	0.793561872690156	0.999999165026057	0.811221593202956	6469	1
WP2112	IL-17 signaling pathway	2/644	27/6049	0.798803969804141	0.999999165026057	0.811221593202956	1051/3605	2
WP2525	Trans-sulfuration and one-carbon metabolism	2/644	27/6049	0.798803969804141	0.999999165026057	0.811221593202956	875/29968	2
WP2533	Glycerophospholipid biosynthetic pathway	2/644	27/6049	0.798803969804141	0.999999165026057	0.811221593202956	2819/5320	2
WP5085	Vasopressin-regulated water reabsorption	3/644	39/6049	0.800474993053449	0.999999165026057	0.811221593202956	398/84699/9586	3
WP1772	Apoptosis modulation and signaling	7/644	84/6049	0.805114346436886	0.999999165026057	0.811221593202956	597/330/664/834/843/8739/8794	7
WP4630	Measles virus infection	10/644	117/6049	0.812749906363878	0.999999165026057	0.811221593202956	3310/3552/3553/3559/3569/4939/8503/6504/6772/7097	10
WP3940	One-carbon metabolism and related pathways	3/644	40/6049	0.814375686488472	0.999999165026057	0.811221593202956	64902/586/6648	3
WP4222	Phosphodiesterases in neuronal function	3/644	40/6049	0.814375686488472	0.999999165026057	0.811221593202956	2906/10846/5142	3
WP4481	Resistin as a regulator of inflammation	2/644	28/6049	0.815211131308781	0.999999165026057	0.811221593202956	3569/7124	2
WP5038	Mitochondrial immune response to SARS-CoV-2	2/644	28/6049	0.815211131308781	0.999999165026057	0.811221593202956	1636/59272	2
WP1946	Cori cycle	1/644	15/6049	0.815591061420486	0.999999165026057	0.811221593202956	6514	1
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	1/644	15/6049	0.815591061420486	0.999999165026057	0.811221593202956	201294	1
WP4962	Airway smooth muscle cell contraction	1/644	15/6049	0.815591061420486	0.999999165026057	0.811221593202956	952	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/644	15/6049	0.815591061420486	0.999999165026057	0.811221593202956	3091	1
WP314	Fas ligand pathway and stress induction of heat shock proteins	3/644	41/6049	0.827447118351066	0.999999165026057	0.811221593202956	843/3552/7124	3
WP4290	Metabolic reprogramming in colon cancer	3/644	41/6049	0.827447118351066	0.999999165026057	0.811221593202956	229/3101/29968	3
WP49	IL-2 signaling pathway	3/644	41/6049	0.827447118351066	0.999999165026057	0.811221593202956	3559/9021/6772	3
WP3972	PDGFR-beta pathway	2/644	29/6049	0.830411728038356	0.999999165026057	0.811221593202956	5159/6772	2
WP4321	Thermogenesis	8/644	98/6049	0.833485857156354	0.999999165026057	0.811221593202956	2180/2182/126129/84699/9586/5600/6300/5593	8
WP22	IL-9 signaling pathway	1/644	16/6049	0.835272757881408	0.999999165026057	0.811221593202956	6772	1
WP4815	Glycosaminoglycan degradation	1/644	16/6049	0.835272757881408	0.999999165026057	0.811221593202956	3373	1
WP4970	Galanin receptor pathway	1/644	16/6049	0.835272757881408	0.999999165026057	0.811221593202956	3569	1
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5/644	65/6049	0.836323392697903	0.999999165026057	0.811221593202956	941/9076/22943/4311/5329	5
WP195	IL-1 signaling pathway	4/644	54/6049	0.841497267487525	0.999999165026057	0.811221593202956	6347/3552/3553/11213	4
WP143	Fatty acid beta-oxidation	2/644	30/6049	0.844476247895606	0.999999165026057	0.811221593202956	2180/2182	2
WP3858	Toll-like receptor signaling related to MyD88	2/644	30/6049	0.844476247895606	0.999999165026057	0.811221593202956	7097/51311	2
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	5/644	66/6049	0.845976642636699	0.999999165026057	0.811221593202956	3638/3949/4597/6319/6713	5
WP1971	Integrated cancer pathway	3/644	43/6049	0.85123676183798	0.999999165026057	0.811221593202956	994/4312/6772	3
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	1/644	17/6049	0.852856769803234	0.999999165026057	0.811221593202956	728689	1
WP5200	Dravet syndrome	1/644	17/6049	0.852856769803234	0.999999165026057	0.811221593202956	5600	1
WP2636	Common pathways underlying drug addiction	2/644	31/6049	0.857473868637813	0.999999165026057	0.811221593202956	72/2893	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/644	31/6049	0.857473868637813	0.999999165026057	0.811221593202956	3283/4318	2
WP2064	Neural crest differentiation	5/644	68/6049	0.863873765147934	0.999999165026057	0.811221593202956	4488/4854/4855/6615/7291	5
WP4217	Ebola virus infection in host	10/644	124/6049	0.864126879119563	0.999999165026057	0.811221593202956	432/684/93978/2318/3119/3134/3678/8503/9021/6772	10
WP3670	Interactions between LOXL4 and oxidative stress pathway	1/644	18/6049	0.868566358703552	0.999999165026057	0.811221593202956	2252	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/644	18/6049	0.868566358703552	0.999999165026057	0.811221593202956	22808	1
WP3995	Prion disease pathway	2/644	32/6049	0.86947193822025	0.999999165026057	0.811221593202956	10538/6688	2
WP231	TNF-alpha signaling pathway	7/644	92/6049	0.872582009240531	0.999999165026057	0.811221593202956	330/6347/3569/1326/6401/7124/7185	7
WP4396	Nonalcoholic fatty liver disease	11/644	137/6049	0.8768459112264	0.999999165026057	0.811221593202956	6347/84701/3552/3553/3569/56901/9971/8503/5313/9021/7124	11
WP3529	Zinc homeostasis	2/644	33/6049	0.88053558031056	0.999999165026057	0.811221593202956	7780/169026	2
WP4542	Leukocyte-intrinsic Hippo pathway functions	2/644	33/6049	0.88053558031056	0.999999165026057	0.811221593202956	50943/639	2
WP4874	CAMKK2 pathway	2/644	33/6049	0.88053558031056	0.999999165026057	0.811221593202956	3383/4094	2
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	2/644	33/6049	0.88053558031056	0.999999165026057	0.811221593202956	4939/6772	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1/644	19/6049	0.882601056928541	0.999999165026057	0.811221593202956	8877	1
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	1/644	19/6049	0.882601056928541	0.999999165026057	0.811221593202956	3091	1
WP5103	Progeria-associated lipodystrophy	1/644	19/6049	0.882601056928541	0.999999165026057	0.811221593202956	2200	1
WP5194	Synthesis of ceramides and 1-deoxyceramides	1/644	19/6049	0.882601056928541	0.999999165026057	0.811221593202956	8877	1
WP400	p38 MAPK signaling pathway	2/644	34/6049	0.890727404277791	0.999999165026057	0.811221593202956	6772/7042	2
WP4262	Breast cancer pathway	10/644	129/6049	0.893427962554681	0.999999165026057	0.811221593202956	2255/2252/2254/11211/4854/4855/8503/7480/7472/7474	10
WP2507	Nanomaterial induced apoptosis	1/644	20/6049	0.895139186171994	0.999999165026057	0.811221593202956	5551	1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/644	20/6049	0.895139186171994	0.999999165026057	0.811221593202956	3002	1
WP4725	Sphingolipid metabolism overview	1/644	20/6049	0.895139186171994	0.999999165026057	0.811221593202956	8877	1
WP2637	Interleukin-1 (IL-1) structural pathway	3/644	49/6049	0.906246992081787	0.999999165026057	0.811221593202956	3552/1326/5600	3
WP4288	MTHFR deficiency	1/644	21/6049	0.906340109062231	0.999999165026057	0.811221593202956	2906	1
WP4726	Sphingolipid metabolism: integrated pathway	1/644	21/6049	0.906340109062231	0.999999165026057	0.811221593202956	8877	1
WP4905	1q21.1 copy number variation syndrome	1/644	21/6049	0.906340109062231	0.999999165026057	0.811221593202956	2702	1
WP4932	7q11.23 copy number variation syndrome	6/644	86/6049	0.907858655085804	0.999999165026057	0.811221593202956	9076/2200/3224/5313/9246/7472	6
WP2447	Amyotrophic lateral sclerosis (ALS)	2/644	36/6049	0.908732315914759	0.999999165026057	0.811221593202956	834/7124	2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/644	36/6049	0.908732315914759	0.999999165026057	0.811221593202956	3488/8744	2
WP623	Oxidative phosphorylation	2/644	36/6049	0.908732315914759	0.999999165026057	0.811221593202956	3002/56901	2
WP2037	Prolactin signaling pathway	5/644	75/6049	0.913321046873939	0.999999165026057	0.811221593202956	3659/4843/8651/9021/6772	5
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	1/644	22/6049	0.916346242068854	0.999999165026057	0.811221593202956	597	1
WP4686	Leucine, isoleucine and valine metabolism	1/644	22/6049	0.916346242068854	0.999999165026057	0.811221593202956	586	1
WP4148	Splicing factor NOVA regulated synaptic proteins	2/644	37/6049	0.916656566716922	0.999999165026057	0.811221593202956	1600/2898	2
WP4249	Hedgehog signaling pathway	2/644	37/6049	0.916656566716922	0.999999165026057	0.811221593202956	2619/6469	2
WP500	Glycogen synthesis and degradation	2/644	38/6049	0.923931227542871	0.999999165026057	0.811221593202956	3099/3101	2
WP3658	Wnt/beta-catenin signaling pathway in leukemia	1/644	23/6049	0.925284854995294	0.999999165026057	0.811221593202956	22943	1
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/644	23/6049	0.925284854995294	0.999999165026057	0.811221593202956	5054	1
WP4537	Hippo-Yap signaling pathway	1/644	23/6049	0.925284854995294	0.999999165026057	0.811221593202956	3627	1
WP4541	Hippo-Merlin signaling dysregulation	7/644	102/6049	0.928594578407451	0.999999165026057	0.811221593202956	1001/1003/3627/3678/3687/3689/5159	7
WP2355	Corticotropin-releasing hormone signaling pathway	5/644	78/6049	0.929160739790361	0.999999165026057	0.811221593202956	8061/3283/3726/4929/6822	5
WP5124	Alzheimer's disease	18/644	226/6049	0.930126680538056	0.999999165026057	0.811221593202956	775/22943/11211/2906/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7480/7472/7474	18
WP2526	PDGF pathway	2/644	39/6049	0.930604537515273	0.999999165026057	0.811221593202956	5159/6772	2
WP585	Interferon type I signaling pathways	3/644	53/6049	0.931919251383082	0.999999165026057	0.811221593202956	8651/9021/6772	3
WP4521	Glycosylation and related congenital defects	1/644	24/6049	0.933269679652286	0.999999165026057	0.811221593202956	79644	1
WP4925	Unfolded protein response	1/644	24/6049	0.933269679652286	0.999999165026057	0.811221593202956	3553	1
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	1/644	24/6049	0.933269679652286	0.999999165026057	0.811221593202956	2769	1
WP4312	Rett syndrome causing genes	2/644	40/6049	0.936721845464052	0.999999165026057	0.811221593202956	3766/23221	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	5/644	80/6049	0.938236450916034	0.999999165026057	0.811221593202956	183/8503/5320/7124/7474	5
WP2059	Alzheimer's disease and miRNA effects	18/644	229/6049	0.938561988837936	0.999999165026057	0.811221593202956	775/22943/11211/2906/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7480/7472/7474	18
WP4906	3q29 copy number variation syndrome	3/644	55/6049	0.942171118805699	0.999999165026057	0.811221593202956	3091/8503/200931	3
WP268	Notch signaling	2/644	41/6049	0.942325677623692	0.999999165026057	0.811221593202956	4854/4855	2
WP4806	EGFR tyrosine kinase inhibitor resistance	5/644	82/6049	0.946255031420813	0.999999165026057	0.811221593202956	3082/3569/22808/5159/8503	5
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/644	26/6049	0.946773677257888	0.999999165026057	0.811221593202956	1051	1
WP61	Notch signaling pathway	3/644	57/6049	0.950976634775955	0.999999165026057	0.811221593202956	3091/4854/4855	3
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	2/644	43/6049	0.952149436443451	0.999999165026057	0.811221593202956	72/3689	2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2/644	43/6049	0.952149436443451	0.999999165026057	0.811221593202956	7042/7043	2
WP3996	Ethanol effects on histone modifications	1/644	27/6049	0.952464819852263	0.999999165026057	0.811221593202956	8854	1
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	1/644	27/6049	0.952464819852263	0.999999165026057	0.811221593202956	1959	1
WP5102	Familial partial lipodystrophy (FPLD)	1/644	27/6049	0.952464819852263	0.999999165026057	0.811221593202956	5396	1
WP5121	Sphingolipid metabolism in senescence	1/644	27/6049	0.952464819852263	0.999999165026057	0.811221593202956	8877	1
WP4255	Non-small cell lung cancer	4/644	71/6049	0.953111719057448	0.999999165026057	0.811221593202956	1381/1382/8503/6258	4
WP1403	AMP-activated protein kinase (AMPK) signaling	3/644	58/6049	0.954895076904008	0.999999165026057	0.811221593202956	126129/5209/8503	3
WP2038	Microtubule cytoskeleton regulation	2/644	44/6049	0.956441141457355	0.999999165026057	0.811221593202956	2151/11076	2
WP2583	T cell receptor and co-stimulatory signaling	1/644	28/6049	0.957548289798318	0.999999165026057	0.811221593202956	1493	1
WP183	Proteasome degradation	3/644	59/6049	0.958519241103684	0.999999165026057	0.811221593202956	3134/3458/5698	3
WP5072	Modulators of TCR signaling and T cell activation	3/644	59/6049	0.958519241103684	0.999999165026057	0.811221593202956	3937/1326/8651	3
WP2118	Arrhythmogenic right ventricular cardiomyopathy	3/644	60/6049	0.961869133040362	0.999999165026057	0.811221593202956	775/1496/3678	3
WP1601	Fluoropyrimidine activity	1/644	29/6049	0.962088881289745	0.999999165026057	0.811221593202956	1890	1
WP722	Serotonin HTR1 group and FOS pathway	1/644	29/6049	0.962088881289745	0.999999165026057	0.811221593202956	3352	1
WP4566	Translation inhibitors in chronically activated PDGFRA cells	2/644	46/6049	0.963945394289989	0.999999165026057	0.811221593202956	8503/11040	2
WP2034	Leptin signaling pathway	4/644	75/6049	0.965556457232795	0.999999165026057	0.811221593202956	3553/3557/9021/6772	4
WP2363	Gastric cancer network 2	1/644	30/6049	0.966144489337819	0.999999165026057	0.811221593202956	51316	1
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	1/644	30/6049	0.966144489337819	0.999999165026057	0.811221593202956	8503	1
WP3888	VEGFA-VEGFR2 signaling pathway	33/644	409/6049	0.970285412701846	0.999999165026057	0.811221593202956	56999/301/6347/1003/79094/1558/22943/1847/1960/2022/24147/6624/1839/3383/6300/4319/4313/4688/4855/4929/8013/5228/5328/5329/5743/27289/57758/6401/9047/6648/6772/8794/81567	33
WP5224	2q37 copy number variation syndrome	6/644	104/6049	0.971900321359157	0.999999165026057	0.811221593202956	1293/6373/27128/3553/7124/54657	6
WP3998	Prader-Willi and Angelman syndrome	1/644	32/6049	0.973002162881827	0.999999165026057	0.811221593202956	2562	1
WP244	Alpha 6 beta 4 signaling pathway	1/644	33/6049	0.975891743587179	0.999999165026057	0.811221593202956	3918	1
WP3981	miRNA regulation of prostate cancer signaling pathways	1/644	33/6049	0.975891743587179	0.999999165026057	0.811221593202956	5159	1
WP422	MAPK cascade	1/644	33/6049	0.975891743587179	0.999999165026057	0.811221593202956	6300	1
WP185	Integrin-mediated cell adhesion	5/644	94/6049	0.977523046820708	0.999999165026057	0.811221593202956	11131/3678/3687/3689/6300	5
WP3286	Copper homeostasis	2/644	51/6049	0.977662288520253	0.999999165026057	0.811221593202956	79689/54739	2
WP313	Hepatocyte growth factor receptor signaling	1/644	34/6049	0.978472481142009	0.999999165026057	0.811221593202956	3082	1
WP4659	Gastrin signaling pathway	6/644	108/6049	0.978814038807733	0.999999165026057	0.811221593202956	330/9076/4316/8503/5743/5054	6
WP2795	Cardiac hypertrophic response	2/644	53/6049	0.981595833336332	0.999999165026057	0.811221593202956	5320/7124	2
WP4205	MET in type 1 papillary renal cell carcinoma	2/644	53/6049	0.981595833336332	0.999999165026057	0.811221593202956	3082/8503	2
WP4223	Ras signaling	10/644	161/6049	0.982191823683818	0.999999165026057	0.811221593202956	2786/22808/5159/8503/51365/84647/5320/50487/283748/115727	10
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	3/644	70/6049	0.983930460120439	0.999999165026057	0.811221593202956	5743/7042/7043	3
WP35	G protein signaling pathways	4/644	85/6049	0.984523018934169	0.999999165026057	0.811221593202956	2769/2786/3760/5142	4
WP524	G13 signaling pathway	1/644	37/6049	0.984674079758302	0.999999165026057	0.811221593202956	398	1
WP51	Regulation of actin cytoskeleton	7/644	127/6049	0.986114363175931	0.999999165026057	0.811221593202956	2255/2252/2254/22808/5159/5288/8503	7
WP3584	MECP2 and associated Rett syndrome	2/644	56/6049	0.986265528794673	0.999999165026057	0.811221593202956	2893/6890	2
WP4263	Pancreatic adenocarcinoma pathway	4/644	87/6049	0.98686970397709	0.999999165026057	0.811221593202956	8503/6772/7042/7043	4
WP366	TGF-beta signaling pathway	7/644	130/6049	0.988764667422652	0.999999165026057	0.811221593202956	467/1278/50943/3726/4312/4321/3371	7
WP2853	Endoderm differentiation	6/644	118/6049	0.989801082194768	0.999999165026057	0.811221593202956	22943/1846/1847/3227/6772/30009	6
WP4155	Endometrial cancer	2/644	61/6049	0.99161037982575	0.999999165026057	0.811221593202956	1496/8503	2
WP4971	Phosphoinositides metabolism	1/644	44/6049	0.9930689477267	0.999999165026057	0.811221593202956	5288	1
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	2/644	64/6049	0.993775692636816	0.999999165026057	0.811221593202956	6772/7253	2
WP4540	Hippo signaling regulation pathways	3/644	85/6049	0.995865758381212	0.999999165026057	0.811221593202956	1001/1003/5159	3
WP107	Translation factors	1/644	49/6049	0.996070147706878	0.999999165026057	0.811221593202956	728689	1
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	6/644	134/6049	0.997032213797989	0.999999165026057	0.811221593202956	249/1959/2562/4688/6696/6772	6
WP2857	Mesodermal commitment pathway	5/644	122/6049	0.99758799656045	0.999999165026057	0.811221593202956	8553/22943/2296/3624/6615	5
WP481	Insulin signaling	7/644	156/6049	0.998393729640798	0.999999165026057	0.811221593202956	1326/5600/6300/5288/8503/8651/9021	7
WP3680	Physico-chemical features and toxicity-associated pathways	1/644	58/6049	0.998586595531069	0.999999165026057	0.811221593202956	11211	1
WP4022	Pyrimidine metabolism	2/644	81/6049	0.998889888303143	0.999999165026057	0.811221593202956	956/1890	2
WP2261	Glioblastoma signaling pathways	2/644	82/6049	0.99899841459621	0.999999165026057	0.811221593202956	5159/5288	2
WP673	ErbB signaling pathway	2/644	83/6049	0.999096460031014	0.999999165026057	0.811221593202956	1839/8503	2
WP45	G1 to S cell cycle control	1/644	62/6049	0.999103278648019	0.999999165026057	0.811221593202956	84699	1
WP4685	Melanoma	1/644	63/6049	0.999199735730143	0.999999165026057	0.811221593202956	8503	1
WP437	EGF/EGFR signaling pathway	6/644	157/6049	0.999550913891925	0.999999165026057	0.811221593202956	9046/7837/9047/6456/6772/7291	6
WP4656	Joubert syndrome	1/644	71/6049	0.999678244721793	0.999999165026057	0.811221593202956	6469	1
WP179	Cell cycle	3/644	115/6049	0.99976555534053	0.999999165026057	0.811221593202956	994/7042/7043	3
WP23	B cell receptor signaling pathway	2/644	96/6049	0.999766028921321	0.999999165026057	0.811221593202956	27071/4067	2
WP138	Androgen receptor signaling pathway	1/644	85/6049	0.999934884312651	0.999999165026057	0.811221593202956	8431	1
WP2446	Retinoblastoma gene in cancer	1/644	86/6049	0.999941915584055	0.999999165026057	0.811221593202956	994	1
WP4549	Fragile X syndrome	1/644	101/6049	0.99998956217899	0.999999165026057	0.811221593202956	4318	1
WP4352	Ciliary landscape	5/644	203/6049	0.999998513399934	0.999999165026057	0.811221593202956	875/30845/3934/2040/339488	5
WP4803	Ciliopathies	2/644	144/6049	0.999998617611812	0.999999165026057	0.811221593202956	122481/10309	2
WP411	mRNA processing	1/644	123/6049	0.999999165026057	0.999999165026057	0.811221593202956	10772	1
